(Q36884728)

16 August 2017

Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis (English)

1 reference

16 August 2017

Karen H Lu

1

1 reference

16 August 2017

17 July 2007

1 reference

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

1

1 reference

16 August 2017

53-58

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-007-9144-x

16 August 2017

0 references

cites work

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10689-007-9144-X

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10689-007-9144-X

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

12 December 2020

Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium

1 reference

12 December 2020

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

1 reference

12 December 2020

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.

1 reference

12 December 2020

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy

1 reference

12 December 2020

The reduction in risk of ovarian cancer associated with oral-contraceptive use

1 reference

12 December 2020

Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

1 reference

12 December 2020

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations

1 reference

12 December 2020

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

1 reference

12 December 2020

Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases

1 reference

12 December 2020

Cancer statistics, 2006

1 reference

12 December 2020

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

1 reference

12 December 2020

Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer

1 reference

12 December 2020

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

12 December 2020

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

1 reference

12 December 2020

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer

1 reference

12 December 2020

Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.

1 reference

12 December 2020

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

1 reference

12 December 2020

Ovarian cancer, oral contraceptives, and BRCA mutations

1 reference

12 December 2020

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

12 December 2020

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers

1 reference

12 December 2020

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.

1 reference

12 December 2020

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

12 December 2020

Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development

1 reference

12 December 2020

Cancer risk associated with germline DNA mismatch repair gene mutations

1 reference

12 December 2020

Cancer risk in mutation carriers of DNA-mismatch-repair genes

1 reference

12 December 2020

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study

1 reference

12 December 2020

10.1007/S10689-007-9144-X

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17636427